DeepMed Research

Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Bacterial Microbiota In The Tonsils Of Children

Completed

Conditions: Adenotonsillitis

First Posted Date: 2011-01-05

Last Posted Date: 2023-04-26

Lead Sponsor: University of Chicago

Target Recruit Count: 24

Registration Number: NCT01270243

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

NasoNeb Delivery of an Intranasal Steroid

Phase 4

Completed

Conditions: Perennial Allergic Rhinitis

Interventions: Drug: Budesonide
Drug: Placebo

First Posted Date: 2011-01-05

Last Posted Date: 2014-07-25

Lead Sponsor: University of Chicago

Target Recruit Count: 41

Registration Number: NCT01270256

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Cardiometabolic Risk of Shiftwork

Terminated

Conditions: Circadian Dysregulation
Shift-Work Sleep Disorder
Sleep Deprivation

Interventions: Behavioral: sleep extension & circadian alignment

First Posted Date: 2010-12-22

Last Posted Date: 2016-10-03

Lead Sponsor: University of Chicago

Target Recruit Count: 64

Registration Number: NCT01264913

Locations: 🇺🇸
The University of Chicago, Chicago, Illinois, United States

Non-cancer Pain and Cognitive Impairment: A Disabling Relationship

Phase 4

Terminated

Conditions: Cognitive Impairment
Arthritis
Pain

Interventions: Drug: extra strength acetaminophen
Drug: long acting oxycodone

First Posted Date: 2010-12-22

Last Posted Date: 2020-12-11

Lead Sponsor: University of Chicago

Target Recruit Count: 25

Registration Number: NCT01264965

Locations: 🇺🇸
University of Chicago Medical Center Outpatient Senior Health Center South Shore, Chicago, Illinois, United States

A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response

Phase 1

Terminated

Conditions: Osteosarcoma
Lung Metastases

Interventions: Drug: Dexrazoxane
Drug: Doxorubicin
Drug: Cisplatin
Drug: G-CSF
Drug: PEG-filgrastim
Drug: Etoposide
Drug: Ifosfamide
Drug: Mesna
Drug: Leucovorin

First Posted Date: 2010-12-13

Last Posted Date: 2013-12-10

Lead Sponsor: University of Chicago

Target Recruit Count: 2

Registration Number: NCT01258634

Locations: 🇺🇸
University of Chicago Department of Pediatrics Hematology/Oncology, Chicago, Illinois, United States

Partial Breast Irradiation in a Low-risk Population Screened With MRI

Not Applicable

Withdrawn

Conditions: Breast Cancer

First Posted Date: 2010-12-07

Last Posted Date: 2014-03-04

Lead Sponsor: University of Chicago

Registration Number: NCT01255553

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Islet Transplantation in Type 1 Diabetic Kidney Allograft

Phase 2

Recruiting

Conditions: Diabetes Mellitus, Type 1

Interventions: Biological: Allogenic islet cells (human, U. Chicago)
Procedure: Intraportal infusion of islet cells

First Posted Date: 2010-11-16

Last Posted Date: 2024-11-26

Lead Sponsor: University of Chicago

Target Recruit Count: 10

Registration Number: NCT01241864

Locations: 🇺🇸
The University of Chicago, Chicago, Illinois, United States

In Vivo nCLE Study in the Pancreas With Endosonography of Cystic Tumors

Not Applicable

Completed

Conditions: Pancreatic Cysts

Interventions: Device: Cellvizio needle-based Confocal Laser Endomicroscopy (nCLE) system

First Posted Date: 2010-11-07

Last Posted Date: 2016-06-08

Lead Sponsor: University of Chicago

Target Recruit Count: 66

Registration Number: NCT01236300

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Topical Allstate and Nasal Allergen Challenge

Phase 3

Withdrawn

Conditions: Allergic Rhinitis

Interventions: Device: Allstate Nasal Spray
Device: Placebo Nasal Spray

First Posted Date: 2010-11-01

Last Posted Date: 2013-06-03

Lead Sponsor: University of Chicago

Registration Number: NCT01231724

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Primary Care Internet-Based Depression Prevention for Adolescents (CATCH-IT)

Phase 3

Withdrawn

Conditions: Substance Abuse
Depression
Anxiety
Externalizing Symptoms

Interventions: Behavioral: CATCH-IT
Behavioral: AMPE

First Posted Date: 2010-10-27

Last Posted Date: 2012-12-17

Lead Sponsor: University of Chicago

Registration Number: NCT01228890

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸
Access Community Health Network, Chicago, Illinois, United States
🇺🇸
Northshore University Health Systems, Evanston, Illinois, United States

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy